Clinical Trial Update: EGF Ointment for Erlotinib Skin Lesion [Phase 2]

View source ↗

Summary

Phase 2 study updates the use of epidermal growth factor ointment to manage erlotinib-induced skin lesions in patients with non-small cell lung cancer or pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• EGF ointment (epidermal growth factor)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Dong-A University Hospital | Conditions: Non-small Cell Lung Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED